&nbsp;

treemapDesignPage3.html

Apr 2022

Regimen

TRAM

Cancer Type:

Gynecologic,

Ovary

Intent: Palliative

Drugs Used:

trametinib (Unfunded)

Quick Link(s):

Regimen Monograph

May 2022

Regimen

TAFA(MNT)

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Intermediate Grade

Intent: Palliative

Drugs Used:

tafasitamab (Unfunded)

Quick Link(s):

Regimen Monograph

Jul 2023

Regimen

TRAS(MNT)

Cancer Type:

Head and Neck,

Salivary Gland

Intent: Palliative

Drugs Used:

trastuzumab (Unfunded)

Quick Link(s):

Regimen Monograph

Jul 2022

Drug

thiotepa

Other Name(s): Tepadina®

Quick Link(s): Drug Monograph

Jan 2023

Regimen

TRIFTIPI+BEVA

Cancer Type:

Gastrointestinal,

Colorectal,

Small bowel and appendix

Intent: Palliative

Funding:

Exceptional Access Program

trifluridine / tipiracil - In combination with bevacizumab for treatment of metastatic colorectal cancer, according to clinical criteria

New Drug Funding Program

Bevacizumab (Biosimilar) - In Combination with Trifluridine and Tipiracil for Previously Treated Metastatic Colorectal Cancer

trifluridine / tipiracil,

Drugs Used:

bevacizumab

Quick Link(s):

Regimen Monograph

Nov 2024

Regimen

TISL(MNT)

Cancer Type:

Head and Neck,

Nasopharynx

Intent: Palliative

Drugs Used:

tislelizumab (Unfunded)

Quick Link(s):

Regimen Monograph

Apr 2024

Document

test.png

Jun 2024

Document

TammyQuigley.png

Nov 2024

Regimen

TRAS(MNT)

Cancer Type:

Gastrointestinal,

Esophagus,

Gastric / Stomach

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab and Trastuzumab (Biosimilar) - First-line Treatment of Advanced HER2-Positive Gastric or Esophagogastric Junction Adenocarcinoma

Drugs Used:

trastuzumab

Quick Link(s):

Regimen Monograph

Dec 2024

Document

T-cellEngagingAntibodies.pdf

Dec 2024

Document